Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU

术后谵妄的病理生理学以及仿生睡眠在 CSICU 中作为治疗策略的应用

基本信息

  • 批准号:
    10179061
  • 负责人:
  • 金额:
    $ 62.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Delirium is one of the six leading causes of preventable morbidity and mortality in hospitalized elderly patients. Individuals with advanced age and Alzheimer's disease are at greatest risk of developing delirium. A substantial proportion of patients who survive delirium are likely to experience long-term cognitive impairment similar to mild Alzheimer's disease, and require institutional care. This suggests that delirium and Alzheimer's disease share pathophysiological features that arise in the context of normal aging. Conditions associated with delirium are characterized by activation of the inflammatory cascade with acute release of inflammatory mediators into the bloodstream. A putative mechanism is the high interleukin-6 level that has been associated with delirium in both laboratory animals and humans. Normal aging is associated with a morphological shift of glia to an activated state. Following a systemic challenge such as critical illness, these activated glia result in an exaggerated neuroinflammatory state associated with delirium. Neuroinflammation is further exacerbated by sleep disturbances. Thus, sleep deprivation may be a modifiable risk factor for the development of delirium. However, pharmacological treatment with no current medication (benzodiazepines, antipsychotics) induces natural sleep or reliably reduces the incidence of delirium. We have found that biomimetic sleep, defined here as pharmacological induction of rapid eye movement sleep (REM) and non-REM I-III sleep states using dexmedetomidine, can now be achieved in humans. Our Specific Aims seek to: (1) investigate the benefits of preemptive biomimetic sleep for reducing the risk of developing delirium in a randomize; (2) investigate the cellular and molecular mechanisms of delirium using combined Positron Emission Tomography/Magnetic Resonance imaging and serum metabolic profiling; and (3) investigate predictors of delirium from perioperative electroencephalogram recordings. At the conclusion of these studies, we will have expanded our knowledge of the pathophysiology of delirium, evaluated a new preemptive therapeutic strategy for delirium, suggest neurophysiologically based monitoring strategies to reduce significantly the amount of anesthetic administered to elderly patients – and possibly delirium – while being certain the patient is sufficiently unconscious for surgery (individualized anesthesia care), and enable continued investigation into the pathophysiology of this clinically important disorder.
谵妄是住院老年患者可预防的发病率和死亡率的六大主要原因之一。 患有阿尔茨海默病的高龄人士患谵妄 A 的风险最大。 大部分在谵妄中幸存的患者可能会出现长期认知障碍 与轻度阿尔茨海默病相似,需要机构护理这表明谵妄和阿尔茨海默病。 疾病具有与正常衰老相关的病理生理学特征。 谵妄的特征是炎症级联的激活和炎症的急性释放 一种推测的机制是相关的高白细胞介素 6 水平。 实验动物和人类的谵妄都与正常衰老有关。 神经胶质细胞进入激活状态后,如危重疾病,这些激活的神经胶质细胞会导致 与谵妄相关的过度神经炎症状态会因谵妄而进一步加剧。 因此,睡眠不足可能是发生谵妄的一个可改变的危险因素。 然而,目前没有药物(苯二氮卓类药物、抗精神病药物)的药物治疗会诱发 自然睡眠或可靠地降低谵妄的发生率我们发现仿生睡眠(此处定义)。 作为快速眼动睡眠 (REM) 和非 REM I-III 睡眠状态的药物诱导,使用 右美托咪定现在可以在人类身上实现,我们的具体目标是:(1)研究其益处。 (2) 随机研究先发性仿生睡眠以降低发生谵妄的风险; 使用正电子发射断层扫描/磁力结合谵妄的细胞和分子机制 共振成像和血清代谢分析;(3) 研究围手术期谵妄的预测因素 在这些研究结束时,我们将扩展我们的知识。 谵妄的病理生理学,评估了一种新的谵妄先发性治疗策略,建议 基于神经生理学的监测策略可显着减少麻醉剂的用量 老年患者可能会出现谵妄,同时确定患者已经完全失去知觉 手术(个体化麻醉护理),并能够继续研究其病理生理学 临床上重要的疾病。

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sex Differences in the Incidence of Postoperative Delirium after Cardiac Surgery: A Pooled Analyses of Clinical Trials.
心脏手术后谵妄发生率的性别差异:临床试验的汇总分析。
  • DOI:
    10.1097/aln.0000000000004656
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Wiredu,Kwame;Mueller,Ariel;McKay,TinaB;Behera,Alkananda;Shaefi,Shahzad;Akeju,Oluwaseun
  • 通讯作者:
    Akeju,Oluwaseun
Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS): protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial.
  • DOI:
    10.1136/bmjopen-2017-020316
  • 发表时间:
    2018-04-20
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Shelton KT;Qu J;Bilotta F;Brown EN;Cudemus G;D'Alessandro DA;Deng H;DiBiasio A;Gitlin JA;Hahm EY;Hobbs LE;Houle TT;Ibala R;Loggia ML;Pavone KJ;Shaefi S;Tolis G;Westover MB;Akeju O
  • 通讯作者:
    Akeju O
Association of Poor Sleep Burden in Middle Age and Older Adults With Risk for Delirium During Hospitalization.
A Systematic Review and Meta-Analysis Examining the Impact of Sleep Disturbance on Postoperative Delirium.
  • DOI:
    10.1097/ccm.0000000000003400
  • 发表时间:
    2018-12
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Fadayomi AB;Ibala R;Bilotta F;Westover MB;Akeju O
  • 通讯作者:
    Akeju O
A polysomnography study examining the association between sleep and postoperative delirium in older hospitalized cardiac surgical patients.
  • DOI:
    10.1111/jsr.13322
  • 发表时间:
    2021-10
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Ibala R;Mekonnen J;Gitlin J;Hahm EY;Ethridge BR;Colon KM;Marota S;Ortega C;Pedemonte JC;Cobanaj M;Chamadia S;Qu J;Gao L;Barbieri R;Akeju O
  • 通讯作者:
    Akeju O
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oluwaseun Johnson-Akeju其他文献

Oluwaseun Johnson-Akeju的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oluwaseun Johnson-Akeju', 18)}}的其他基金

Investigation of a Novel Biomarker of Postoperative Delirium
术后谵妄的新型生物标志物的研究
  • 批准号:
    10452901
  • 财政年份:
    2022
  • 资助金额:
    $ 62.68万
  • 项目类别:
Investigation of a Novel Biomarker of Postoperative Delirium
术后谵妄的新型生物标志物的研究
  • 批准号:
    10640891
  • 财政年份:
    2022
  • 资助金额:
    $ 62.68万
  • 项目类别:

相似国自然基金

TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
  • 批准号:
    82220108016
  • 批准年份:
    2022
  • 资助金额:
    252 万元
  • 项目类别:
    国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
  • 批准号:
    81800806
  • 批准年份:
    2018
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
  • 批准号:
    81700824
  • 批准年份:
    2017
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
  • 批准号:
    81670269
  • 批准年份:
    2016
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
  • 批准号:
    31470998
  • 批准年份:
    2014
  • 资助金额:
    87.0 万元
  • 项目类别:
    面上项目

相似海外基金

The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
  • 批准号:
    10678125
  • 财政年份:
    2023
  • 资助金额:
    $ 62.68万
  • 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
  • 批准号:
    10678789
  • 财政年份:
    2023
  • 资助金额:
    $ 62.68万
  • 项目类别:
Impact of TBI and Cognitive Decline on Alzheimer's Disease Brain-Derived Exosome Cargo
TBI 和认知能力下降对阿尔茨海默病脑源性外泌体货物的影响
  • 批准号:
    10662883
  • 财政年份:
    2023
  • 资助金额:
    $ 62.68万
  • 项目类别:
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
  • 批准号:
    10643269
  • 财政年份:
    2023
  • 资助金额:
    $ 62.68万
  • 项目类别:
Recruitment of Cerebellar Circuits with Balance Training for Cognitive Rehabilitation in a Mouse Model of Mild Traumatic Brain Injury
在轻度创伤性脑损伤小鼠模型中通过平衡训练募集小脑回路进行认知康复
  • 批准号:
    10753349
  • 财政年份:
    2023
  • 资助金额:
    $ 62.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了